Loading…
History from 2026-05-04 to 2026-10-30. Every number below is a fact from TED/TenderNed notices — who this buyer awards to, what it buys, and what is open right now.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| SANOFI AVENTIS, S.A | 3 | €4.1B | 2026-10-26 |
| SOCIEDAD ESTATAL CORREOS Y TELÉGRAFOS, S.A. S.M.E. | 3 | €2.7M | 2026-07-08 |
| INCYTE BIOSCIENCES IBERIA, S.L | 1 | €4.0B | 2026-10-30 |
| DAIICHI SANKYO ESPAÑA, S.A | 1 | €4.0B | 2026-10-27 |
| GLAXOSMITHKLINE, S.A | 1 | €4.0B | 2026-10-28 |
| AMICUS THERAPEUTICS, SLU | 1 | €4.0B | 2026-10-27 |
| ASTRAZENECA FARMACÉUTICA SPAIN, S.A | 1 | €4.0B | 2026-10-27 |
| BRISTOL MYERS SQUIBB, S.A | 1 | €4.0B | 2026-10-27 |
| BAYER HISPANIA, S.L | 1 | €4.0B | 2026-10-27 |
| BIOMARIN PHARMACEUTICALS ESPAÑA, S.L | 1 | €4.0B | 2026-10-27 |
| BEONE MEDICINES ESP, SLU | 1 | €4.0B | 2026-10-27 |
| CSL BEHRING, S.A | 1 | €4.0B | 2026-10-27 |
| Category | Notices | Open | Latest |
|---|---|---|---|
33 Medical equipment & pharmaceuticals | 65 | 0 | 2026-10-30 |
45 Construction work | 5 | 0 | 2026-07-09 |
64 Postal & telecommunications services | 3 | 0 | 2026-07-08 |
55 Hotel, restaurant & retail trade | 2 | 0 | 2026-09-21 |
71 Architecture, engineering & inspection | 1 | 0 | 2026-06-22 |
09 Petroleum, fuel, electricity & energy | 1 | 0 | 2026-06-25 |
77 Agricultural, forestry & horticultural services | 1 | 0 | 2026-09-22 |
24 Chemical products | 1 | 0 | 2026-05-05 |
42 Industrial machinery | 1 | 0 | 2026-08-14 |
50 Repair & maintenance services | 1 |
| 2026-08-14 |
Recurring categories with no open notice are re-tender candidates — this buyer has bought them before and will again.
| won by GLAXOSMITHKLINE, S.A |
| €4,010,802,463 |
| 2026-10-28 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 203184, CON LA EMPRESA JANSSEN-CILAG, S.A | won by JANSSEN-CILAG, S.A | €4,010,802,463 |
| 2026-10-28 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 208780, CON LA EMPRESA KYOWA KIRIN FARMACEUTICA, S.L | won by KYOWA KIRIN FARMACEUTICA, S.L | €4,010,802,463 |
| 2026-10-27 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 208771, CON LA EMPRESA BEONE MEDICINES ESP, SLU | won by BEONE MEDICINES ESP, SLU | €4,010,802,463 |
| 2026-10-27 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 208770, CON LA EMPRESA BAYER HISPANIA, S.L | won by BAYER HISPANIA, S.L | €4,010,802,463 |
| 2026-10-27 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 20328765, CON LA EMPRESA AMICUS THERAPEUTICS, SLU | won by AMICUS THERAPEUTICS, SLU | €4,010,802,463 |
| 2026-10-27 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 208768, CON LA EMPRESA ASTRAZENECA FARMACÉUTICA SPAIN, S.A. | won by ASTRAZENECA FARMACÉUTICA SPAIN, S.A | €4,010,802,463 |
| 2026-10-27 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 208773, CON LA EMPRESA BRISTOL MYERS SQUIBB, S.A | won by BRISTOL MYERS SQUIBB, S.A | €4,010,802,463 |
| 2026-10-27 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 208774, CON LA EMPRESA CSL BEHRING, S.A | won by CSL BEHRING, S.A | €4,010,802,463 |
| 2026-10-27 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 208775, CON LA EMPRESA DAIICHI SANKYO ESPAÑA, S.A | won by DAIICHI SANKYO ESPAÑA, S.A | €4,010,802,463 |
| 2026-10-27 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 203213, CON LA EMPRESA VERTEX PHARMACEUTICALS SPAIN, S.L | won by VERTEX PHARMACEUTICALS SPAIN, S.L | €4,010,802,463 |
| 2026-10-27 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 202982, CON LA EMPRESA GILEAD SCIENCES, S.L | won by GILEAD SCIENCES, S.L | €4,010,802,463 |
| 2026-10-27 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 208772, CON LA EMPRESA BIOMARIN PHARMACEUTICALS ESPAÑA, S.L | won by BIOMARIN PHARMACEUTICALS ESPAÑA, S.L | €4,010,802,463 |
| 2026-10-26 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 203205, CON LA EMPRESA SANOFI AVENTIS, S.A | won by SANOFI AVENTIS, S.A | €4,010,802,463 |
| 2026-10-26 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 208789, CON LA EMPRESA ROCHE FARMA, S.A | won by ROCHE FARMA, S.A | €4,010,802,463 |
| 2026-10-26 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 203212, CON LA EMPRESA UCB PHARMA, S.A | won by UCB PHARMA, S.A | €4,010,802,463 |
| 2026-10-22 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 203209, CON LA EMPRESA TAKEDA FARMACÉUTICA ESPAÑA, S.A | won by TAKEDA FARMACÉUTICA ESPAÑA, S.A. | €4,010,802,463 |
| 2026-10-22 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 203211, CON LA EMPRESA TEVA PHARMA, S.L | won by TEVA PHARMA, S.L | €4,010,802,463 |
| 2026-10-22 | EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 203199, CON LA EMPRESA PFIZER, S.L | won by PFIZER, S.L | €164,527,501 |